By ALLEN C. HO, MD; ROBERT L . AVERY, MD; and DAVID S. BOYER, MD
By JENNIFER KREATSOULAS, PHD, SENIOR EDITOR
By WITH WILLIAM L. RICH III, MD
By STEPHEN DAILY, NEWS EDITOR
By ARON SHAPIRO; MICHAEL BYRNES, PHD; AND ASHLEY LAFOND
With GREG FENTON, MD; AND CHIRAG P. SHAH, MD
By BRUCE MALLER
By MEHRAN TABAN, MD; CHRISTINE SONNIE, RN; BRANDY C. HAYDEN, BS; AND JONATHAN E. SEARS, MD
By MARÍA H. BERROCAL, MD
By ROHIT ROSS LAKHANPAL, MD, FACS
By MELISSA MURPHY; NINA NI, MD; AND CAROL L. SHIELDS, MD
By PETER A. CAMPOCHIARO, MD
By ANNE FUNG, MD
Reviewed by DAVID S. BOYER, MD
By CHRISTOPHER SCHÜTZE, MD; AND URSULA SCHMIDT-ERFURTH, MD
Attention to patients’ needs can help design the best treatment regimen.
By MICHAEL A. SINGER, MD
By NANCY M. HOLEKAMP, MD
By JEFFREY K. LUTTRULL, MD
By EHAB EL RAYES, MD, PHD
Oral administration of 75 mg ACU-4429 (Acucela Inc., Seattle, WA), which produced a dose-dependent inhibition of the b-wave of electroretinograms, was well tolerated and demonstrated linear pharmacokinetics across doses, accor... more >
In patients with age-related macular degeneration (AMD), bevacizumab (Avastin, Genentech) and ranibizumab (Lucentis, Genentech) had equivalent effects on visual acuity when administered in the same dosing regimen. This was acc... more >
Low-dose Iluvien (fluocinolone acetonide, Alimera Sciences) was most effective in patients with diabetic macular edema (DME) who had the disease for 3 years or more, according to a recent analysis of the data from the 36-month... more >
The number of patients receiving coronary artery bypass graft (CABG) surgery decreased dramatically between 2001 and 2008, according to a study in the Journal of the American Medical Association.sup1/sup Researchers at the U... more >
Advertisement
Reviewed by DAVID S. BOYER, MD
By PETER A. CAMPOCHIARO, MD
By MELISSA MURPHY; NINA NI, MD; AND CAROL L. SHIELDS, MD
By ALLEN C. HO, MD
By ROHIT ROSS LAKHANPAL, MD, FACS